Despite headwinds from Covid-19, robust sales at Hoka One One and Teva helped limit the damage for Deckers Brands’ revenues in its fourth fiscal quarter, ended on March 31. The group’s quarterly sales declined by 4.9 percent to $374.9 million, or by 4.5 percent in constant currencies, while net income fell by 32.9 percent to $13.6 million. Hoka’s sales jumped by 51.8 percent to $101.9 million, driven by online sales and new products. The management said the brand’s digital presence is its core strength and represents the ultimate access point. The number of retained and newly acquired customers nearly doubled year-over-year in the brand’s global direct-to-consumer business. Teva also did well, climbing by 12.5 percent to $59.6 million. But for the group’s biggest brand, Ugg, sales dropped by 17.9 percent to $196.3 million, weighed down by Covid-19 restrictions. For the full fiscal year, Deckers’ sales grew by 5.6 percent to $2,132 million, while net income jumped by 4.5 percent to $273.2 million. Ugg was down by 0.8 percent, Hoka jumped by 58.0 percent and Sanuk fell by 38.1 percent, while Teva inched up 0.4 percent. More in Shoe Intelligence.